LONDON Can society afford modern medicines? It's a question facing governments worldwide and nowhere more so than in Britain, where a new budget test due to take effect on April 1 threatens to throw up another hurdle to patients getting the drugs.
NEW YORK The amount that drugmaker Mylan NV avoided paying the U.S. government in Medicaid rebates for its EpiPen emergency allergy treatment since 2007 likely exceeds a proposed $465 million settlement the company announced in October, according to a study by private drug pricing experts published on Monday.
GENEVA The health situation is deteriorating in Syria's eastern Ghouta region near Damascus, where 300,000 people are besieged and none of the three hospitals is functioning, the World Health Organization said on Monday in a call for access to deliver aid.
The U.S. Food and Drug Administration on Monday approved Tesaro Inc's drug, niraparib, for the treatment of recurrent ovarian cancer.
STOCKHOLM Sweden's center-left government proposed legislation on Monday that would grant compensation to transgender men and women who had to undergo mandatory sterilization in order to have their sex legally reassigned.